Report cover image

Nocturia Industry Research Report 2025

Publisher APO Research, Inc.
Published Jul 06, 2025
Length 140 Pages
SKU # APRC20260846

Description

Summary

According to APO Research, The global Nocturia market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Nocturia is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Nocturia is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Nocturia is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Nocturia include Abbott, Allergan, APOTEX INC, Astellas Pharma, Astra Zeneca, Bristol-Myers Squibb, Eli Lilly, Ferring Pharmaceuticals and GlaxoSmithKline, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nocturia, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nocturia.
The Nocturia market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nocturia market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Nocturia Segment by Company

Abbott
Allergan
APOTEX INC
Astellas Pharma
Astra Zeneca
Bristol-Myers Squibb
Eli Lilly
Ferring Pharmaceuticals
GlaxoSmithKline
Johnson & Johnson
Merck
Mylan
Novartis
Pfizer
Rechon Life Science AB
Sagent Pharmaceuticals
Sanofi
Sun Pharmaceutical Industries Ltd.
Teva
Chengdu Leer Pharmaceutical
Fosun Pharma
Hainan Zhonghe Pharmaceutical
Nanjing Xingyin Pharmaceutical Group
Hybio Pharmaceutical
Zhejiang Conba Pharmaceutical
Nocturia Segment by Type

Desmopressin
Diuretics
Anticholinergic Drugs
Alpha Blockers
Others
Nocturia Segment by Application

Retail Pharmacies
Online Pharmacies
Hospital Pharmacies
Nocturia Segment by Application

Retail Pharmacies
Online Pharmacies
Hospital Pharmacies
Nocturia Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Middle East & Africa

Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nocturia market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nocturia and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nocturia.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Nocturia companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

140 Pages
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Nocturia by Type
2.2.1 Market Value Comparison by Type (2020 VS 2024 VS 2031)
2.2.2 Desmopressin
2.2.3 Diuretics
2.2.4 Anticholinergic Drugs
2.2.5 Alpha Blockers
2.2.6 Others
2.3 Nocturia by Application
2.3.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.3.2 Retail Pharmacies
2.3.3 Online Pharmacies
2.3.4 Hospital Pharmacies
2.4 Assumptions and Limitations
3 Nocturia Breakdown Data by Type
3.1 Global Nocturia Historic Market Size by Type (2020-2025)
3.2 Global Nocturia Forecasted Market Size by Type (2026-2031)
4 Nocturia Breakdown Data by Application
4.1 Global Nocturia Historic Market Size by Application (2020-2025)
4.2 Global Nocturia Forecasted Market Size by Application (2026-2031)
5 Global Growth Trends
5.1 Global Nocturia Market Perspective (2020-2031)
5.2 Global Nocturia Growth Trends by Region
5.2.1 Global Nocturia Market Size by Region: 2020 VS 2024 VS 2031
5.2.2 Nocturia Historic Market Size by Region (2020-2025)
5.2.3 Nocturia Forecasted Market Size by Region (2026-2031)
5.3 Nocturia Market Dynamics
5.3.1 Nocturia Industry Trends
5.3.2 Nocturia Market Drivers
5.3.3 Nocturia Market Challenges
5.3.4 Nocturia Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Nocturia Players by Revenue
6.1.1 Global Top Nocturia Players by Revenue (2020-2025)
6.1.2 Global Nocturia Revenue Market Share by Players (2020-2025)
6.2 Global Nocturia Industry Players Ranking, 2023 VS 2024 VS 2025
6.3 Global Key Players of Nocturia Head Office and Area Served
6.4 Global Nocturia Players, Product Type & Application
6.5 Global Nocturia Manufacturers Established Date
6.6 Global Nocturia Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Nocturia Market Size (2020-2031)
7.2 North America Nocturia Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 North America Nocturia Market Size by Country (2020-2025)
7.4 North America Nocturia Market Size by Country (2026-2031)
7.5 United States
7.5 United States
7.6 Canada
7.7 Mexico
8 Europe
8.1 Europe Nocturia Market Size (2020-2031)
8.2 Europe Nocturia Market Growth Rate by Country: 2020 VS 2024 VS 2031
8.3 Europe Nocturia Market Size by Country (2020-2025)
8.4 Europe Nocturia Market Size by Country (2026-2031)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Spain
8.10 Russia
8.11 Netherlands
8.12 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Nocturia Market Size (2020-2031)
9.2 Asia-Pacific Nocturia Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Asia-Pacific Nocturia Market Size by Country (2020-2025)
9.4 Asia-Pacific Nocturia Market Size by Country (2026-2031)
9.5 China
9.6 Japan
9.7 South Korea
9.8 India
9.9 Australia
9.10 China Taiwan
9.11 Southeast Asia
10 South America
10.1 South America Nocturia Market Size (2020-2031)
10.2 South America Nocturia Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 South America Nocturia Market Size by Country (2020-2025)
10.4 South America Nocturia Market Size by Country (2026-2031)
10.5 Brazil
10.6 Argentina
10.7 Chile
10.8 Colombia
10.9 Peru
11 Middle East & Africa
11.1 Middle East & Africa Nocturia Market Size (2020-2031)
11.2 Middle East & Africa Nocturia Market Growth Rate by Country: 2020 VS 2024 VS 2031
11.3 Middle East & Africa Nocturia Market Size by Country (2020-2025)
11.4 Middle East & Africa Nocturia Market Size by Country (2026-2031)
11.5 Saudi Arabia
11.6 Israel
11.7 United Arab Emirates
11.8 Turkey
11.9 Iran
11.10 Egypt
12 Players Profiled
12.1 Abbott
12.1.1 Abbott Company Information
12.1.2 Abbott Business Overview
12.1.3 Abbott Revenue in Nocturia Business (2020-2025)
12.1.4 Abbott Nocturia Product Portfolio
12.1.5 Abbott Recent Developments
12.2 Allergan
12.2.1 Allergan Company Information
12.2.2 Allergan Business Overview
12.2.3 Allergan Revenue in Nocturia Business (2020-2025)
12.2.4 Allergan Nocturia Product Portfolio
12.2.5 Allergan Recent Developments
12.3 APOTEX INC
12.3.1 APOTEX INC Company Information
12.3.2 APOTEX INC Business Overview
12.3.3 APOTEX INC Revenue in Nocturia Business (2020-2025)
12.3.4 APOTEX INC Nocturia Product Portfolio
12.3.5 APOTEX INC Recent Developments
12.4 Astellas Pharma
12.4.1 Astellas Pharma Company Information
12.4.2 Astellas Pharma Business Overview
12.4.3 Astellas Pharma Revenue in Nocturia Business (2020-2025)
12.4.4 Astellas Pharma Nocturia Product Portfolio
12.4.5 Astellas Pharma Recent Developments
12.5 Astra Zeneca
12.5.1 Astra Zeneca Company Information
12.5.2 Astra Zeneca Business Overview
12.5.3 Astra Zeneca Revenue in Nocturia Business (2020-2025)
12.5.4 Astra Zeneca Nocturia Product Portfolio
12.5.5 Astra Zeneca Recent Developments
12.6 Bristol-Myers Squibb
12.6.1 Bristol-Myers Squibb Company Information
12.6.2 Bristol-Myers Squibb Business Overview
12.6.3 Bristol-Myers Squibb Revenue in Nocturia Business (2020-2025)
12.6.4 Bristol-Myers Squibb Nocturia Product Portfolio
12.6.5 Bristol-Myers Squibb Recent Developments
12.7 Eli Lilly
12.7.1 Eli Lilly Company Information
12.7.2 Eli Lilly Business Overview
12.7.3 Eli Lilly Revenue in Nocturia Business (2020-2025)
12.7.4 Eli Lilly Nocturia Product Portfolio
12.7.5 Eli Lilly Recent Developments
12.8 Ferring Pharmaceuticals
12.8.1 Ferring Pharmaceuticals Company Information
12.8.2 Ferring Pharmaceuticals Business Overview
12.8.3 Ferring Pharmaceuticals Revenue in Nocturia Business (2020-2025)
12.8.4 Ferring Pharmaceuticals Nocturia Product Portfolio
12.8.5 Ferring Pharmaceuticals Recent Developments
12.9 GlaxoSmithKline
12.9.1 GlaxoSmithKline Company Information
12.9.2 GlaxoSmithKline Business Overview
12.9.3 GlaxoSmithKline Revenue in Nocturia Business (2020-2025)
12.9.4 GlaxoSmithKline Nocturia Product Portfolio
12.9.5 GlaxoSmithKline Recent Developments
12.10 Johnson & Johnson
12.10.1 Johnson & Johnson Company Information
12.10.2 Johnson & Johnson Business Overview
12.10.3 Johnson & Johnson Revenue in Nocturia Business (2020-2025)
12.10.4 Johnson & Johnson Nocturia Product Portfolio
12.10.5 Johnson & Johnson Recent Developments
12.11 Merck
12.11.1 Merck Company Information
12.11.2 Merck Business Overview
12.11.3 Merck Revenue in Nocturia Business (2020-2025)
12.11.4 Merck Nocturia Product Portfolio
12.11.5 Merck Recent Developments
12.12 Mylan
12.12.1 Mylan Company Information
12.12.2 Mylan Business Overview
12.12.3 Mylan Revenue in Nocturia Business (2020-2025)
12.12.4 Mylan Nocturia Product Portfolio
12.12.5 Mylan Recent Developments
12.13 Novartis
12.13.1 Novartis Company Information
12.13.2 Novartis Business Overview
12.13.3 Novartis Revenue in Nocturia Business (2020-2025)
12.13.4 Novartis Nocturia Product Portfolio
12.13.5 Novartis Recent Developments
12.14 Pfizer
12.14.1 Pfizer Company Information
12.14.2 Pfizer Business Overview
12.14.3 Pfizer Revenue in Nocturia Business (2020-2025)
12.14.4 Pfizer Nocturia Product Portfolio
12.14.5 Pfizer Recent Developments
12.15 Rechon Life Science AB
12.15.1 Rechon Life Science AB Company Information
12.15.2 Rechon Life Science AB Business Overview
12.15.3 Rechon Life Science AB Revenue in Nocturia Business (2020-2025)
12.15.4 Rechon Life Science AB Nocturia Product Portfolio
12.15.5 Rechon Life Science AB Recent Developments
12.16 Sagent Pharmaceuticals
12.16.1 Sagent Pharmaceuticals Company Information
12.16.2 Sagent Pharmaceuticals Business Overview
12.16.3 Sagent Pharmaceuticals Revenue in Nocturia Business (2020-2025)
12.16.4 Sagent Pharmaceuticals Nocturia Product Portfolio
12.16.5 Sagent Pharmaceuticals Recent Developments
12.17 Sanofi
12.17.1 Sanofi Company Information
12.17.2 Sanofi Business Overview
12.17.3 Sanofi Revenue in Nocturia Business (2020-2025)
12.17.4 Sanofi Nocturia Product Portfolio
12.17.5 Sanofi Recent Developments
12.18 Sun Pharmaceutical Industries Ltd.
12.18.1 Sun Pharmaceutical Industries Ltd. Company Information
12.18.2 Sun Pharmaceutical Industries Ltd. Business Overview
12.18.3 Sun Pharmaceutical Industries Ltd. Revenue in Nocturia Business (2020-2025)
12.18.4 Sun Pharmaceutical Industries Ltd. Nocturia Product Portfolio
12.18.5 Sun Pharmaceutical Industries Ltd. Recent Developments
12.19 Teva
12.19.1 Teva Company Information
12.19.2 Teva Business Overview
12.19.3 Teva Revenue in Nocturia Business (2020-2025)
12.19.4 Teva Nocturia Product Portfolio
12.19.5 Teva Recent Developments
12.20 Chengdu Leer Pharmaceutical
12.20.1 Chengdu Leer Pharmaceutical Company Information
12.20.2 Chengdu Leer Pharmaceutical Business Overview
12.20.3 Chengdu Leer Pharmaceutical Revenue in Nocturia Business (2020-2025)
12.20.4 Chengdu Leer Pharmaceutical Nocturia Product Portfolio
12.20.5 Chengdu Leer Pharmaceutical Recent Developments
12.21 Fosun Pharma
12.21.1 Fosun Pharma Company Information
12.21.2 Fosun Pharma Business Overview
12.21.3 Fosun Pharma Revenue in Nocturia Business (2020-2025)
12.21.4 Fosun Pharma Nocturia Product Portfolio
12.21.5 Fosun Pharma Recent Developments
12.22 Hainan Zhonghe Pharmaceutical
12.22.1 Hainan Zhonghe Pharmaceutical Company Information
12.22.2 Hainan Zhonghe Pharmaceutical Business Overview
12.22.3 Hainan Zhonghe Pharmaceutical Revenue in Nocturia Business (2020-2025)
12.22.4 Hainan Zhonghe Pharmaceutical Nocturia Product Portfolio
12.22.5 Hainan Zhonghe Pharmaceutical Recent Developments
12.23 Nanjing Xingyin Pharmaceutical Group
12.23.1 Nanjing Xingyin Pharmaceutical Group Company Information
12.23.2 Nanjing Xingyin Pharmaceutical Group Business Overview
12.23.3 Nanjing Xingyin Pharmaceutical Group Revenue in Nocturia Business (2020-2025)
12.23.4 Nanjing Xingyin Pharmaceutical Group Nocturia Product Portfolio
12.23.5 Nanjing Xingyin Pharmaceutical Group Recent Developments
12.24 Hybio Pharmaceutical
12.24.1 Hybio Pharmaceutical Company Information
12.24.2 Hybio Pharmaceutical Business Overview
12.24.3 Hybio Pharmaceutical Revenue in Nocturia Business (2020-2025)
12.24.4 Hybio Pharmaceutical Nocturia Product Portfolio
12.24.5 Hybio Pharmaceutical Recent Developments
12.25 Zhejiang Conba Pharmaceutical
12.25.1 Zhejiang Conba Pharmaceutical Company Information
12.25.2 Zhejiang Conba Pharmaceutical Business Overview
12.25.3 Zhejiang Conba Pharmaceutical Revenue in Nocturia Business (2020-2025)
12.25.4 Zhejiang Conba Pharmaceutical Nocturia Product Portfolio
12.25.5 Zhejiang Conba Pharmaceutical Recent Developments
13 Report Conclusion
14 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.